Akershus University Hospital — Clinical Trial Site

170 Registered trials

76 Currently recruiting

Organisation

Akershus University Hospital

Location

Loerenskog, Norway

Identifier

ORG-100010785

Address

Sykehusveien 27, 1478, Norway

Departments

..
4403: Hjertemedisinsk avdeling
5201: Hematology
6202: Avdeling for nyresykdommer
Akershus Universitetssykehus HF
Akershus University Hospital
Akershus University Hospital, Lørenskog
Anesthesia
Avdeling for Blodsykdommer
Avdeling for fordøyelsessykdommer, Gastrolab
Avdeling for lungesykdommer
Avdeling for Onkologi, Nye Nord, Nordbyhagen
Barne- og Ungdomsklinikken
Cardiology
Department for internal medicine and lab subjects
Department for lung diseases
Department of Cardiac Disease
Department of Cardiology
Department of Cardiology, Akershus University Hospital (Ahus)
Department of Endocrinology
Department of Gastroenterology
Department of Haematology
Department of hematology
Department of Infectious Diseases
Department of Medicine
Department of Neurology
Department of Obstetrics and Gynecology
Department of Oncology
Department of Palliative Medicine
Department of Pulmonology
Department of Surgery
Department of Urology, Surgical Division
Department Pediatrics and Adolescent Medicine
Dept. of Gastroenterology B202
Dept. Of Hematology Akershus universitetssykehus (AHUS)
Dept. of Neurology
Dept. of Pulmonary Medicine
Dept. Paediatric and Adolescent Medicine
Division of Medicine
Division of Medicine and Laboratory Sciences
Division of mental health and addiction
Division of research and innovation
Doctor of Medicine
DPS Groruddalen
Dpt of gastrointestinal surgery
Dpt of Oncollogy
Dpt of oncology
Gastro
Gastro dep
Gastroenterology
Gastrolab B102
Gastromedisin
Gastromedisinsk avdeling
Haematology
Hematologisk avdeling
Hematology
Hematology department
Hjertemed. avd.
Hjertemedisinsk avdeling
Infectious Diseases
Institution Location Name Avdeling for fordøyelsessykdommer, gastrolab
Kreftavdelingen
Kvinneklinikken, Observasjonsavdelingen
Lungeavdeling Ahus
Lungeavdelingen
Lungepoliklinikken
Lungepoliklinikken B105
Medical Oncology
Medisinsk divisjon
N/A
Neurology
Nevrologisk avdeling
NO10001:Gastrolab B202
NO10003: Gastrolab B202
Nyremedisinsk avdeling
Old age psychiatry
Oncology
Oncology (Onkologisk avdeling)
Oncology Department
Onkologisk Avdeling
Orthopedic Surgery
Øre-nese-hals avdeling
Palliativ avdeling
Pediatrics
Pulmanory Medicine Department
Pulmonary department
Stroke
Surgical department
Urologisk Avdeling

Clinical trials at this site (170)

Search interface

A research study to find out whether a medicine called inclisiran helps to prevent cardiovascular death, heart attacks or strokes in people … Ended

2024-510735-21-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2021-11-26
A rollover extension program (REP) to evaluate the long-term safety and tolerability of open label iptacopan in adult participants with prim… Ended

2023-508690-92-00 IgA Nephropathy 11 2021-09-20
An Open-label, Randomized Phase 3 Study of Immune and Targeted Combination Therapies, as First-line Treatment in Participants with Advanced … Ended

2022-502122-41-00 Clear cell renal cancer 5 2021-05-11
A phase 3 multicentre, randomized, prospective, open-label trial of Ibrutinib monotherapy versus fixed-duration Venetoclax plus Obinutuzumab… Ended

2022-500439-35-00 treatment-naive chronic lymphocytic leukemia 5 2021-02-11
POLAR BEAR Ended

2022-502887-19-00 Diffuse Large B-Cell Lymphoma 5 2020-08-18
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell… Ended

2023-503591-25-00 Non-small cell lung cancer 5 2020-06-09
TALAPRO 2: A PHASE 3, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATION RESISTANT… Ended

2023-509087-20-00 Metastatic Castration-resistant Prostate Cancer 5 2019-04-16
A Phase 3 trial of BCG with or without pembrolizumab for High Risk Non Muscle Invasive Bladder Cancer Ended

2022-501817-29-00 High Risk Non-muscle invasive bladder cancer 5 2018-11-27
A randomized phase II study comparing atezolizumab after concurrent chemoradiotherapy with chemoradiotherapy alone in limited disease small-… Ended

2024-515755-37-00 Limited disease small-cell lung cancer 4 2018-07-31
RAM-MS Ended

2024-510630-40-00 Multiple sclerosis 5 2018-02-12
A Placebo controlled Maintenance and Long-term Extension Study of the Efficacy and Safety of Risankizumab in Participants with Crohn's Disea… Ended

2023-506399-28-00 Crohn's Disease 5 2017-11-08
Long Term Safety and Efficacy of ABT-494 in Subjects with Ulcerative Colitis. Ended

2023-505699-31-00 Ulcerative Colitis 5 2017-01-02
Dopamine agonist treatment of non-functioning pituitary adenomas (NFPAs) – a randomized controlled trial Ended

2023-510039-12-00 Non-functioning pituitary adenoma 6 2014-09-01
A Phase 3, Open-Label, Long-Term Safety Extension Study Evaluating the Safety and Tolerability of the Fixed-Dose Combination of Obeticholic … Ended

2023-507771-22-01 Primary Biliary Cholangitis (PBC) 5 2025-04-03
A PHASE 1B DOSE RANGE FINDING STUDY OF PHENSERINE COMPARED TO DONEPEZIL IN PARTICIPANTS WITH EARLY OR MILD ALZHEIMER’S DISEASE Ended

2023-510282-10-00 Mild Cognitive Impairment 3 2025-02-11
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
The TAF-MS study Ended

2023-503814-62-00 Multiple sclerosis 4 2024-02-06
A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC) Ended

2023-507027-37-00 Primary Sclerosing Cholangitis (PSC) 3 2023-07-20
Long-term Efficacy and Safety of Tozorakimab in Participants with Chronic Obstructive Pulmonary Disease with a History of Exacerbations. Ended

2022-501063-41-00 Chronic Obstructive Pulmonary Disease (COPD) 5 2023-04-20
A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adults with Cardiomyopathy Ended

2023-506352-24-00 Non-obstructive Hypertrophic Cardiomyopathy 5 2023-04-13
A Study to Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn’s Disease Ended

2024-511089-36-00 Crohn’s disease 4 2023-03-17
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Prevention of ischemic stroke in patients post acute no 5 2023-01-18
A Phase IIa Study to assess Safety, Tolerability, and Pharmacodynamics of AZD4831 in Adult Participants with Non-cirrhotic NASH with Fibrosi… Ended

2022-500594-13-00 "Non-Alcoholic Steatohepatatis (NASH) is the progressiv 4 2022-12-14